FeesSafety
Pluang+

Ocean Power Technologies advances US Army and NATO trials, boosting commercial prospects.

Market News
12 Sep 2026
Proactive Investors
View Source
Bullish
Ocean Power Technologies advances US Army and NATO trials, boosting commercial prospects.

Ocean Power Technologies is expanding its operational trials with the U.S. Army in North Carolina and NATO in Europe, focusing on challenging coastal and maritime environments. These trials involve drones navigating surf zones, carrying payloads, deploying sensors, and collecting data to support military and security applications like beach access, hazard detection, port security, and mine countermeasures. CEO Philipp Stratmann highlighted that these real-world deployments help build backlog and revenue potential, reflecting growing global attention on maritime safety and defense. The company aims to convert these demonstrations into commercial contracts, leveraging its readiness to deploy systems quickly and cost-effectively.

More News

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...

Market News
Bullish
1 hour ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...

Market News
Bullish
1 hour ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...

Market News
Bullish
1 hour ago
Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...

Market News
Bullish
1 hour ago
Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App